Pfizer buys Amplyx to expand drug-resistant treatment portfolio
Pfizer Inc on Wednesday said it has acquired privately-held Amplyx Pharmaceuticals, which is developing a new treatment for drug-resistant "superbug" fungal infections in patients with compr